NOW ENROLLING PHASE 3

Help us advance kidney disease research

The AMPLITUDE clinical research study is a Phase 2/3 adaptive study aiming to improve the knowledge of chronic kidney disease and potentially create better treatment options for future generations.

Do you know someone who may be able to take part?

You can review the key eligibility criteria on the
‘Who can take part?’ page. If you know someone who may meet the eligibility criteria, we’d love to hear from you.